Can You Stop Taking Blood Thinners? Essential Guide

Stopping a blood thinner is not a decision you make on your own. For most people on these medications, the drug is doing a specific job — preventing clots that can cause stroke, heart attack, or pulmonary embolism — and stopping it without a plan from your doctor can put you at real risk within days. That said, some people genuinely can stop, usually after the original reason for the drug has resolved or changed. The only safe path is a clinical decision made with the prescriber who knows your history.

What Are Blood Thinners Actually Doing in Your Body?

Blood thinners do not actually thin blood. That name is misleading. These drugs slow down or interrupt the clotting process so that clots form less easily or not at all.

There are two broad categories. Anticoagulants — such as warfarin, apixaban, rivaroxaban, dabigatran, and edoxaban — interfere with proteins in the coagulation cascade. Antiplatelet drugs — such as aspirin, clopidogrel, and ticagrelor — make platelets less likely to stick together and form a clot.

They are used for different problems. Anticoagulants are typically prescribed for atrial fibrillation, deep vein thrombosis, pulmonary embolism, and mechanical heart valves. Antiplatelets are typically prescribed after a heart attack, stent placement, or certain types of stroke.

Understanding which type you take — and why — is the first step in any conversation about stopping. The two categories are not interchangeable, and the risks of stopping them are not the same.

Can You Stop Taking Blood Thinners on Your Own?

No. Stopping a blood thinner without medical guidance can be dangerous, and in some situations it can be fatal.

When you stop an anticoagulant, its protective effect fades over hours to days, depending on the drug. Warfarin’s effect wears off over roughly five days. Direct oral anticoagulants like apixaban and rivaroxaban lose most of their effect within 24 to 48 hours. Once that protection is gone, the underlying risk of clotting returns to whatever it was before — or higher, if the original clot-provoking condition is still present.

For someone with atrial fibrillation, that means a stroke risk that may have been substantially reduced by the medication returns to its untreated level. For someone who had a pulmonary embolism, it means a new clot could form in the lungs.

There are also situations where stopping abruptly is particularly hazardous. If you have a mechanical heart valve or a recently placed coronary stent, stopping your medication without a plan can lead to a clot forming on the valve or inside the stent — events that are often catastrophic.

If you are having side effects, bleeding, or simply want to know whether you still need the drug, the right move is to call your prescriber. Do not stop first and ask later.

Why Would a Doctor Decide to Stop a Blood Thinner?

There are several legitimate reasons a clinician might take someone off a blood thinner, and they fall into a few recognizable categories.

• The original problem resolved. A provoked deep vein thrombosis — one that happened after surgery or a period of immobility — is often treated for a defined period, typically three to six months. After that, if the provoking factor is gone and there is no ongoing risk, some patients can stop.
• The risk of bleeding now outweighs the benefit of clotting prevention. This is common in older adults who have had falls, gastrointestinal bleeding, or a decline in kidney function that changes how the drug is cleared.
• The medication is being switched, not stopped. Sometimes a patient moves from warfarin to a direct oral anticoagulant, or from one drug to another, because of side effects, cost, or interactions. This is a change, not a discontinuation.
• A procedure requires it. Many surgeries and dental procedures require pausing a blood thinner for a short window. This is usually done with specific instructions about when to stop and when to restart.
• The patient’s goals of care have changed. In advanced illness or when a patient chooses to focus on comfort, anticoagulation may be stopped as part of a broader plan.

Notice what is not on this list: feeling fine, being tired of taking pills, or reading that a drug has risks. Those are reasons to have a conversation, not reasons to stop.

How Do Doctors Decide Whether You Still Need It?

The decision usually comes down to weighing two risks against each other: the risk of a clot if you stop, and the risk of serious bleeding if you continue.

For atrial fibrillation, clinicians commonly use a scoring system called CHA₂DS₂-VASc to estimate stroke risk. It assigns points for factors like age, heart failure, high blood pressure, diabetes, prior stroke, and vascular disease. Higher scores generally mean a stronger case for staying on an anticoagulant. A separate score, HAS-BLED, estimates bleeding risk.

Neither score is a verdict. They are tools that inform a conversation. A high stroke score with a low bleeding score usually points toward continuing. A high bleeding score with a low stroke score may point toward stopping — but the threshold is a clinical judgment, not a fixed number.

For venous thromboembolism, the key questions are whether the clot was provoked or unprovoked, whether it was the first event or a recurrence, and whether the patient has an ongoing condition like cancer that raises clotting risk. A first provoked clot in someone whose provoking factor has resolved is often treated for a limited period. An unprovoked clot or a recurrent one often leads to longer or indefinite treatment.

For antiplatelet drugs after a stent, timing matters enormously. Stopping too early after stent placement can cause the stent to clot, which is a medical emergency. The safe window depends on the type of stent and the reason it was placed, and only the treating cardiologist can determine it.

What Happens If You Stop Without Telling Anyone?

The consequences depend on why you were on the drug, but the general pattern is the same: protection fades, and the original risk returns.

With atrial fibrillation, the concern is stroke. Atrial fibrillation allows blood to pool in part of the heart, where clots can form and then travel to the brain. Anticoagulation reduces that risk substantially — but it does not eliminate it, and stopping removes most of the reduction.

With a prior DVT or PE, the concern is a new clot. The risk is highest in the first months after stopping, particularly if the original clot was unprovoked or if a risk factor like cancer or a clotting disorder is still present.

With a mechanical heart valve, the concern is a clot forming on the valve itself, which can block the valve or send fragments to the brain or other organs. This is one of the situations where stopping an anticoagulant can be rapidly life-threatening.

With a coronary stent, the concern is stent thrombosis — a clot forming inside the stent. This is uncommon but often results in a large heart attack.

There is also a subtler issue: rebound. Some evidence suggests that after stopping certain anticoagulants, the clotting system may be temporarily more active than it was before treatment started. The evidence here is not uniform across drugs, and researchers continue to study it, but it is one more reason that stopping is not a neutral act.

What Should You Do If You Want to Stop?

Start with a conversation, not a decision. Call your prescriber’s office and say plainly: “I want to review whether I still need this medication.” That single sentence opens the right discussion.

Before that conversation, it helps to gather a few things:

• The exact name and dose of your medication
• Why it was originally prescribed, and when
• Any bleeding, bruising, or side effects you have noticed
• Any upcoming procedures or dental work
• Any new medications, including over-the-counter drugs and supplements

That last point matters more than many people realize. Common over-the-counter drugs like ibuprofen and naproxen increase bleeding risk when combined with anticoagulants. So do some supplements, including fish oil at high doses, ginkgo, and turmeric. Your clinician needs the full picture.

If you and your doctor decide to stop, ask how. Some drugs need to be tapered or overlapped with another medication. Some can simply be stopped. The answer depends on which drug you take and why.

If you and your doctor decide to continue, ask what would change that. Knowing the specific factors that would prompt a reevaluation — a fall, a bleeding episode, a change in kidney function — gives you a clearer sense of the plan.

Are There Alternatives to Stopping?

Sometimes the right answer is not stopping but adjusting. A different anticoagulant may cause fewer side effects for you. A lower dose may be appropriate if your kidney function has changed. A different antiplatelet regimen may be safer after a stent.

For people at high bleeding risk who still need protection, clinicians sometimes consider procedures like left atrial appendage closure in atrial fibrillation. This is a device-based option that can reduce stroke risk without long-term anticoagulation in selected patients. It is not appropriate for everyone, and it carries its own procedural risks. It is a decision made with a cardiologist, not a substitute for one.

What is not an alternative is switching to a supplement or a “natural blood thinner” on your own. Some supplements do affect clotting, but none has been shown in large human trials to provide the same stroke or clot protection as prescription anticoagulants. Substituting one for the other is not a safer choice — it is an unprotected one.